Interleukin (IL)-21 is the most recently recognized of the cytokines that share the common cytokine receptor γ chain (γc), which is mutated in humans with X-linked severe combined immunodeficiency. We now report that IL-21 synergistically acts with IL-15 to potently promote the proliferation of both memory (CD44high) and naive (CD44low) phenotype CD8+ T cells and augment interferon-γ production in vitro. IL-21 also cooperated, albeit more weakly, with IL-7, but not with IL-2. Correspondingly, the expansion and cytotoxicity of CD8+ T cells were impaired in IL-21R−/− mice. Moreover, in vivo administration of IL-21 in combination with IL-15 boosted antigen-specific CD8+ T cell numbers and resulted in a cooperative effect on tumor regression, with apparent cures of large, established B16 melanomas. Thus, our studies reveal that IL-21 potently regulates CD8+ T cell expansion and effector function, primarily in a synergistic context with IL-15.
Skip Nav Destination
Article navigation
3 January 2005
Article|
January 03 2005
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
Rong Zeng,
Rong Zeng
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Search for other works by this author on:
Rosanne Spolski,
Rosanne Spolski
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Search for other works by this author on:
Steven E. Finkelstein,
Steven E. Finkelstein
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
SangKon Oh,
SangKon Oh
3Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Panu E. Kovanen,
Panu E. Kovanen
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Search for other works by this author on:
Christian S. Hinrichs,
Christian S. Hinrichs
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Cynthia A. Pise-Masison,
Cynthia A. Pise-Masison
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Michael F. Radonovich,
Michael F. Radonovich
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
John N. Brady,
John N. Brady
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Nicholas P. Restifo,
Nicholas P. Restifo
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Jay A. Berzofsky,
Jay A. Berzofsky
3Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Warren J. Leonard
Warren J. Leonard
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Search for other works by this author on:
Rong Zeng
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Rosanne Spolski
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Steven E. Finkelstein
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
SangKon Oh
3Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Panu E. Kovanen
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
Christian S. Hinrichs
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Cynthia A. Pise-Masison
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Michael F. Radonovich
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
John N. Brady
4Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Nicholas P. Restifo
2Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Jay A. Berzofsky
3Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Warren J. Leonard
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute
CORRESPONDENCE Warren J. Leonard: [email protected]
Abbreviations used: CFSE, 5,6-carboxyfluorescein diacetate succinimidyl ester; rFPVhgp100, recombinant fowlpox virus encoding hgp100; vPE16, vaccinia virus–expressing HIV gp160.
Received:
May 28 2004
Accepted:
November 23 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (1): 139–148.
Article history
Received:
May 28 2004
Accepted:
November 23 2004
Citation
Rong Zeng, Rosanne Spolski, Steven E. Finkelstein, SangKon Oh, Panu E. Kovanen, Christian S. Hinrichs, Cynthia A. Pise-Masison, Michael F. Radonovich, John N. Brady, Nicholas P. Restifo, Jay A. Berzofsky, Warren J. Leonard; Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function . J Exp Med 3 January 2005; 201 (1): 139–148. doi: https://doi.org/10.1084/jem.20041057
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement